Aug 20, 2021 This Week in Cardiology Podcast


Manage episode 300390419 series 2291284
Player FM과 저희 커뮤니티의 Medscape Podcasts 콘텐츠는 모두 원 저작자에게 속하며 Player FM이 아닌 작가가 저작권을 갖습니다. 오디오는 해당 서버에서 직접 스트리밍 됩니다. 구독 버튼을 눌러 Player FM에서 업데이트 현황을 확인하세요. 혹은 다른 팟캐스트 앱에서 URL을 불러오세요.

COVID-19, Simpson’s Paradox, LAA appendage closure, multimorbidity, and an ESC preview are the topics John Mandrola, MD discusses in today’s podcast.

1 - COVID-19

- Lacking Beds, Hospitals Ship COVID-19 Patients to Other States

- Efficacy and Safety of Same-Day Discharge for Atrial Fibrillation Ablation

2 - Simpson’s Paradox

- Israeli data: How can efficacy vs. severe disease be strong when 60% of hospitalized are vaccinated?

- Simpson’s Paradox and Interpreting Data

- How SIMPSON'S PARADOX explains weird COVID19 statistics

3 - Left Atrial Appendage Closure

- FDA Approves Abbott's Amplatzer Amulet for Atrial Fibrillation

- Chronic Kidney Disease Tied to Worse LAAO Outcomes

- The Association of Chronic Kidney Disease With Outcomes Following Percutaneous Left Atrial Appendage Closure

- Prophylactic Use of Implantable Cardioverter-Defibrillators in the Prevention of Sudden Cardiac Death in Dialysis

4 - ESC Preview

- SGLT2 inhibitors in HFpEF

- EMPEROR-Preserved: Positive Top-Line Results for Empagliflozin in HFpEF

- AF Screening

- Atrial fibrillation detected by continuous electrocardiographic monitoring using implantable loop recorder to prevent stroke in individuals at risk (the LOOP study): Rationale and design of a large randomized controlled trial

5 - Coming soon

The anticoagulation in COVID-19 trial is one of the hardest I have seen in years. Stay tuned.

You may also like:

Medscape editor-in-chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, on Medicine and the Machine

The Bob Harrington Show with Stanford University Chair of Medicine, Robert A. Harrington, MD.

Questions or feedback, please contact

188 에피소드